These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29203525)

  • 1. Methodological, political and legal issues in the assessment of the effects of nanotechnology on human health.
    Guseva Canu I; Schulte PA; Riediker M; Fatkhutdinova L; Bergamaschi E
    J Epidemiol Community Health; 2018 Feb; 72(2):148-153. PubMed ID: 29203525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Challenges of 21st Century Neurotoxicology: The Case of Neurotoxicology Applied to Nanomaterials.
    Bencsik A; Lestaevel P
    Front Toxicol; 2021; 3():629256. PubMed ID: 35295119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A harmonized protocol for an international multicenter prospective study of nanotechnology workers: the NanoExplore cohort.
    Guseva Canu I; Plys E; Velarde Crézé C; Fito C; Hopf NB; Progiou A; Riganti C; Sauvain JJ; Squillacioti G; Suarez G; Wild P; Bergamaschi E
    Nanotoxicology; 2023 Feb; 17(1):1-19. PubMed ID: 36927342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ONE Nano: NIEHS's strategic initiative on the health and safety effects of engineered nanomaterials.
    Schug TT; Johnson AF; Balshaw DM; Garantziotis S; Walker NJ; Weis C; Nadadur SS; Birnbaum LS
    Environ Health Perspect; 2013 Apr; 121(4):410-4. PubMed ID: 23407114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of nanomaterial characteristics on inhalation toxicity.
    Bierkandt FS; Leibrock L; Wagener S; Laux P; Luch A
    Toxicol Res (Camb); 2018 May; 7(3):321-346. PubMed ID: 30090585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health implications of engineered nanomaterials.
    Pietroiusti A
    Nanoscale; 2012 Feb; 4(4):1231-47. PubMed ID: 22278373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
    Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
    Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From cradle-to-grave at the nanoscale: gaps in U.S. regulatory oversight along the nanomaterial life cycle.
    Beaudrie CE; Kandlikar M; Satterfield T
    Environ Sci Technol; 2013 Jun; 47(11):5524-34. PubMed ID: 23668487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the first wave of epidemiological studies of nanomaterial workers.
    Liou SH; Tsai CS; Pelclova D; Schubauer-Berigan MK; Schulte PA
    J Nanopart Res; 2015 Oct; 17():413. PubMed ID: 26635494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanomaterials: exposures, hazards, and risk prevention.
    Yokel RA; Macphail RC
    J Occup Med Toxicol; 2011 Mar; 6():7. PubMed ID: 21418643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in the impact of engineered nanomaterials on the joint toxicity with environmental pollutants.
    Liu Y; Nie Y; Wang J; Wang J; Wang X; Chen S; Zhao G; Wu L; Xu A
    Ecotoxicol Environ Saf; 2018 Oct; 162():92-102. PubMed ID: 29990744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological and conceptual issues regarding occupational psychosocial coronary heart disease epidemiology.
    Burr H; Formazin M; Pohrt A
    Scand J Work Environ Health; 2016 May; 42(3):251-5. PubMed ID: 26960179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.
    Tinkle SS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):88-98. PubMed ID: 20049833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of Pristine and Transformed Ag and Cu Engineered Nanomaterials on Surficial Sediment Microbial Communities Appear Short-Lived.
    Moore JD; Stegemeier JP; Bibby K; Marinakos SM; Lowry GV; Gregory KB
    Environ Sci Technol; 2016 Mar; 50(5):2641-51. PubMed ID: 26841726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.